Restaging With Prostate-Specific Membrane Antigen Imaging in Metastatic Castration-Resistant Prostate Cancer: When Seeing More Is Detrimental to Care

被引：3

作者：

Madan, Ravi A. ^{[1
]}

Yu, Evan Y. ^{[2
,3
]}

Posadas, Edwin M. ^{[4
]}

Lee, Richard J. ^{[5
]}

Karzai, Fatima ^{[1
]}

Choyke, Peter L. ^{[6
]}

机构：

[1] NCI, Genitourinary Malignancies Branch, Bethesda, MD 20814 USA

[2] Univ Washington, Seattle, WA USA

[3] Fred Hutchinson Canc Ctr, Seattle, WA USA

[4] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA

[5] Harvard Med Sch, Massachusetts Gen Hosp Canc Ctr, Dept Med, Boston, MA USA

[6] NCI, Mol Imaging Branch, Bethesda, MD USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 19期

关键词：

D O I：

10.1200/JCO.23.02727

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

#PSMA is amazing new tech but is using it to expedite the call of disease progression helping #ProstateCancer patients?

引用

页数：4

共 50 条

[41] Comment on: “Modeling the Relationship between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer”
Nuggehally R. Srinivas
Clinical Pharmacokinetics, 2017, 56 : 211 - 212
[42] Relation between plasma trough concentration of abiraterone and prostate-specific antigen response in metastatic castration-resistant prostate cancer patients
Carton, E.
Noe, G.
Huillard, O.
Golmard, L.
Giroux, J.
Cessot, A.
Saidu, N. E. B.
Peyromaure, M.
Zerbib, M.
Narjoz, C.
Guibourdenche, J.
Thomas, A.
Vidal, M.
Goldwasser, F.
Blanchet, B.
Alexandre, J.
EUROPEAN JOURNAL OF CANCER, 2017, 72 : 54 - 61
[43] Effects of 225Ac-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis
Lee, Dong Yun
Kim, Yong-il
JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (06) : 840 - 846
[44] Phase I trial of the prostate-specific membrane antigen directed immunoconjugate MLN2704 in patients with progressive metastatic castration-resistant prostate cancer
Galsky, Matthew D.
Eisenberger, Mario
Moore-Cooper, Sandra
Kelly, W. Kevin
Slovin, Susan F.
DeLaCruz, Anthony
Lee, Yih
Webb, Iain J.
Scher, Howard I.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (13) : 2147 - 2154
[45] Heterogeneity of prostate-specific membrane antigen (PSMA) expression in classic and apoptotic circulating tumor cells (CTC) in metastatic castration-resistant prostate cancer (mCRPC)
Autio, Karen A.
Anand, Aseem
Krupa, Rachel
Louw, Jessica
Arslan, Zaina
Dittamore, Ryan
Scher, Howard I.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
[46] Prostate-specific membrane antigen positron emission tomography-computed tomography use prior to systemic therapy in metastatic castration-resistant prostate cancer
Kelly, Richard
Jensen, Andrew
Karunaratna, Nathasha
Wong, Shirley
Shapiro, Julia
Weickhardt, Andrew
Parente, Phillip
Azad, Arun A.
Uccellini, Anthony
Torres, Javier
Parnis, Francis
Goh, Jeffrey
Kwan, Edmond M.
Brown, Stephen
Steer, Christopher
Warren, Mark
Gibbs, Peter
Tran, Ben
Anton, Angelyn
BJU INTERNATIONAL, 2023, 131 (02) : 179 - 182
[47] Future Prospect of Low-Molecular-Weight Prostate-Specific Membrane Antigen Radioisotopes Labeled as Theranostic Agents for Metastatic Castration-Resistant Prostate Cancer
Ismuha, Ratu Ralna
Ritawidya, Rien
Daruwati, Isti
Muchtaridi, Muchtaridi
MOLECULES, 2024, 29 (24):
[48] Metastatic castration-resistant prostate cancer
Henriques, Vanessa
Wenzel, Mike
Demes, Melanie-Christin
Koellermann, Jens
PATHOLOGE, 2021, 42 (04): : 431 - 438
[49] Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer
Feneley, MR
Jan, H
Granowska, M
Mather, SJ
Ellison, D
Glass, J
Coptcoat, M
Kirby, RS
Ogden, C
Oliver, RTD
Badenoch, DF
Chinegwundoh, FI
Nargund, VH
Paris, AMI
Britton, KE
PROSTATE CANCER AND PROSTATIC DISEASES, 2000, 3 (01) : 47 - 52
[50] Prostate-specific membrane antigen in prostate cancer imaging and treatment
Lim, Emerson
TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S676 - S689

← 1 2 3 4 5 →